HGEN News and Press, Humanigen Inc. From 10/28/20

Socket Mobile (SCKT) +42% as its S550 contactless reader achieves Apple wallet compatibility.AgeX Therapeutics (AGE) +16%.First Solar (FSLR) +12% on Q3 results.Tupperware Brands (TUP) +11% on Q3 results.Scholar Rock Holding (SRRK) +10%.XpresSpa Group (XSPA)&...

The FDA's full approval of Gilead Sciences' (GILD) Veklury (remdesivir) on Thursday, October 22, for severely ill hospitalized COVID-19 patients was the first full nod for such a therapy and sustains the company's leadership position in antiviral treatments against SARS-CoV-2 infection. Remde...

HC Wainwright initiated Humanigen ([[HGEN]] +16.6%) with a Buy rating, PT $31; indicating more than double upside from currently trading levels.Analyst Joseph Pantginis stated that the company's lead asset is lenzilumab and development is furthest along in treating COVID-19 patients.Clinical-...

Interpace Biosciences (IDXG) +72% after completing an independent investigation into complaints and finds it unsubstantiated.Allscripts Healthcare Solutions (MDRX) +38% on announcing to sell its CarePort Health business to WellSky.VOXX International Corporation (VOXX) ...

The National Institute of Allergy and Infectious Diseases ((NIAID)), part of the National Institutes of Health ((NIH)) has launched ACTIV-5 Big Effect trial, to compare different investigational therapies to a common control arm to determine which experimental treatments have relatively large...

Lenzilumab among the promising agents selected for ACTIV program from pool of approximately 400 candidate agents Humanigen, Inc., (Nasdaq: HGEN) (“Humanigen”), a clinical stage biopharmaceutical company focused on preventing and treating an immu...

Lizhi (LIZI) +46%. as Government picks Lizhi its backed pilot program to bolster local online audiovisual industry.Acorn (ATV) +31% on revised going private transaction for $21/share.LMP Automotive (LMPX) +21%. to acquire 70% interest in New York’s largest franchise...

Taiwan Liposome (TLC) +89% after company secures Australian and Taiwan approval to initiate trial of inhaled malaria drug for COVID-19.Ocean Power Technologies (OPTT) +47%.Sunworks (SUNW) +45% on announcing $10M in Q3 project wins.Urban Tea (MYT) +31%.Hill International (H...

Gainers: Kiniksa Pharmaceuticals (KNSA) +18%, Humanigen (HGEN) +15%, Neuronetics (STIM) +16%, American Well (AMWL) +13%, Xtant Medical (XTNT) +5%.Losers: Corbus Pharmaceuticals (CRBP) -39%, Axovant Gene Therapies (AXGT)-20%, Iovance Bioth...

Westwater Resources (WWR) +53%.Xtant Medical Holdings (XTNT) +29% after regaining compliance with NYSE's continued listing standards.Alteryx (AYX) +25% on raising Q3 revenue guidance.CBAK Energy Technology (CBAT) +22%.Ocean Power Technologies (OPTT) +20%.Oxbridge Re Holdin...